Adrixetinib is an inhibitor of protein tyrosine kinase with antineoplastic activity.
References:
[1]. WHO Drug Informat ion - World Health Organization (WHO). [2]. Nam Kiyean, et al. Quinoline derivatives as inhibitors of Axl/Mer RTK and CSF1R and their preparation: World Intellectual Property Organization, WO2019229251. 2019-12-05. [3]. WHO Drug Information-World Health Organization (WHO).